A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

May 8, 2020

Study Completion Date

September 25, 2020

Conditions
Plaque Psoriasis
Interventions
DRUG

Apremilast

Tablets for oral administration

DRUG

Topical Therapy

Participants continued to use their existing topical treatment for psoriasis for the first 16 weeks. After 16 weeks, participants could decrease the use of topical therapy at their discretion under the direction of their physician.

Trial Locations (56)

91054

Research Site, Erlangen

814-0180

Research Site, Fukuoka

Fukuoka University Hospital, Fukuoka-shi, Fukuoka

813-0044

Research Site, Fukuoka-shi, Fukuoka

Kiryu Dermatology Clinic, Fukuoka-shi, Fukuoka

819-0167

Research Site, Fukuoka-shi, Fukuoka

Tomoko Matsuda Dermatology Clinic, Fukuoka-shi, Fukuoka

080-0013

Research Site, Obihiro-shi

Takagi Dermatological Clinic, Obihiro

060-0063

Research Site, Sapporo

Sapporo Skin Clinic, Sapporo-shi, Hokkaido

062-0042

Research Site, Sapporo

Fukuzumi Dermatology Clinic, Sapporo-shi, Hokkaido

593-8324

Research Site, Sakai-shi

Kume Clinic, Sakai-shi, Osaka

113-8603

Research Site, Bunkyo-ku

113-8655

Research Site, Bunkyo-ku

The University of Tokyo Hospital, Bunkyō City

070-0810

Motomachi Dermatology Clinic, Asahikawa-shi, Hokkaido

Research Site, Asahikawa-shi, Hokkaido

113-8602

Nippon Medical School Hospital, Bunkyō City

066-0021

Chitose Dermatology and Plastic, Reconstructive Surgery Clinic, Chitose

Research Site, Chitose

811-3217

Hino Dermatology Clinic, Fukutsu

Research Site, Fukutsu

890-0055

Research Site, Kagoshima

Saruwatari Dermatology Clinic, Kagoshima

861-3101

Noguchi Dermatorogy Clinic, Kamimashiki-gun

Research Site, Kamimashiki-gun

806-8501

Japan Community Health-care Organization Kyushu Hospital, Kitakyushu

Research Site, Kitakyushu

136-0074

Maruyama Dermatology Clinic, Koto-ku, Tokyo

Research Site, Koto-ku, Tokyo

108-0014

Mita Dermatology Clinic, Minatoku

Research Site, Minatoku

020-8505

Iwate Medical University Uchimaru Medical Center, Morioka

Research Site, Morioka

572-0838

Research Site, Neyagawa

Yoshioka Dermatology Clinic, Neyagawa

550-0006

Nippon Life Hospital, Osaka

Research Site, Osaka

599-8272

Hino Clinic, Sakai

Research Site, Sakai

003-0833

Kitagou Dermatology Clinic, Sapporo

Research Site, Sapporo

060-0807

Kobayashi Skin Clinic, Sapporo

Research Site, Sapporo

064-0807

Hosui Medical Clinic, Sapporo

Research Site, Sapporo

329-0498

Jichi Medical University Hospital, Shimotsuke

Research Site, Shimotsuke

141-8625

NTT Medical Center Tokyo, Shinagawa-ku, Tokyo

160-0023

Research Site, Shinjyuku-ku

Tokyo Medical University Hospital, Shinjyuku-ku

470-1192

Fujita Health University Hospital, Toyoake

Research Site, Toyoake

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY